Multiple Sclerosis Clinical Trial
MS PATHS COVID-19 Questionnaire Data Linkage Sub-Study
Summary
The primary objective of this sub-study is to supplement the Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) dataset with coronavirus disease 2019 (COVID-19)-related health information obtained from periodic participant questionnaires administered by participating MS PATHS institutions.
Eligibility Criteria
Key Inclusion Criteria:
Be enrolled in MS PATHS under Study 888MS001.
Completed one or more COVID-19 questionnaire at a participating MS PATHS institution.
Permission for data linkage either obtained when completing a local COVID-19 questionnaire or granted by waiver of informed consent from the local institutional review board (IRB) or ethics committee (EC).
Key Exclusion Criteria:
1. Other unspecified reasons that, in the opinion of the Investigator or Biogen, make the participant unsuitable for participation in the sub-study. A participant only needs to complete the assessments deemed necessary by the Investigator.
Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 5 Locations for this study
Baltimore Maryland, 21287, United States
Saint Louis Missouri, 63110, United States
Las Vegas Nevada, 89106, United States
New York New York, 10016, United States
Cleveland Ohio, 44195, United States
Columbus Ohio, 44195, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.